Kerins Patrick J's Form 4 filing
Minerva Surgical Inc (UTRS) · filed Oct 28, 2021
- Accession no.
- 0001209191-21-061994
- Filed
- Oct 28, 2021, 9:05 PM ET
- Trade date
- Oct 26, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 16 derivative transactions. Open-market purchases total $15.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kerins Patrick JCIK 0001235112 | 10% Owner |
| Sandell Scott DCIK 0001237289 | 10% Owner |
| Baskett ForestCIK 0001277631 | 10% Owner |
| New Enterprise Associates 13 LPCIK 0001452907 | 10% Owner |
| NEA 13 GP, LtdCIK 0001460751 | 10% Owner |
| NEA Partners 13, Limited PartnershipCIK 0001460752 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionAcquired | +596,183 | –F1 | – | 596,183 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +1,190,212 | –F1 | – | 1,786,395 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +3,409,709 | –F1 | – | 5,196,104 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +3,503,021 | –F1 | – | 8,699,125 | Direct | |
| Oct 26, 2021 | Common Stock | PPurchaseAcquired | +1,300,000 | $12.00 | +$15,600,000 | 9,999,125 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionDisposed | −596,183 | –F1 | – | 0 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −1,190,212 | –F1 | – | 0 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −3,409,709 | –F1 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −553,449 | –F3 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −532,334 | –F4 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −517,593 | –F5 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −503,146 | –F6 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −546,012 | –F7 | – | 0 | Direct | |
| Oct 26, 2021 | Series D Preferred Stock | CConversionDisposed | −850,492 | –F8 | – | 0 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +553,449 | –F1 | – | 553,449 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +532,333 | –F1 | – | 1,085,782 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +517,592 | –F1 | – | 1,603,374 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +503,145 | –F1 | – | 2,106,519 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +546,011 | –F1 | – | 2,652,530 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +850,491 | –F1 | – | 3,503,021 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −3,503,021 | –F1 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Referenced by the price of 4 transactions in Table I and 10 transactions in Table II.
- F3
Represents $6,257,308.36 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.
- F4
Represents $6,018,574.40 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.
- F5
Represents $5,851,915.34 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.
- F6
Represents $5,688,578.14 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.
- F7
Represents $6,173,219.88 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.
- F8
Represents $9,615,676.10 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Referenced by the price of 1 transaction in Table II.